Smith, 7, diagnosed with a rare blood disorder, receives a life-saving stem cell transplant from his father, Matt, offering ...

Data from the POLARGO trial potentially establishes a new standard of care for patients with R/R DLBCL ineligible for ...

Haematology's profound transformation offers new hope through advanced diagnostics, personalized medicine, and the noble act ...

Rates of grade III/IV acute GVHD at 3 months were 3% with cyclophosphamide-cyclosporin prophylaxis and 10% with standard ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...

A combination of peripheral blood mesenchymal stem cells (PBMSCs) and platelet rich fibrin matrix (PRFM) could be a probable periodontal regenerative material with the synergy of the added benefits of ...

Anti-aging, which encompasses slow aging and reverse aging that youth cells, has become a health trend. While attention is ...

A FAMILY of a seven-year-old boy diagnosed with a rare and life-threatening blood disorder has urged more people to donate ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

Meanwhile, Murry and his colleagues at the University of Southern California are reprogramming adult blood stem cells to become heart muscle cells that are then transplanted. After decades of stop ...

A 36-year-old female was diagnosed with AML in June 2018. Treatment regimens are shown in Figure 3A. In November 2018, HLA-identical sibling peripheral blood stem cell transplantation was performed.